Search by Drug Name or NDC

    NDC 70114-0340-01 LOQTORZI 240 mg/6mL Details

    LOQTORZI 240 mg/6mL

    LOQTORZI is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Coherus BioSciences, Inc.. The primary component is TORIPALIMAB.

    Product Information

    NDC 70114-0340
    Product ID 70114-340_176dc546-a574-4e35-ab3e-809df4e8f28e
    Associated GPIs
    GCN Sequence Number 085452
    GCN Sequence Number Description toripalimab-tpzi VIAL 240MG/6ML INTRAVEN
    HIC3 V3R
    HIC3 Description ANTINEOPLASTIC,ANTI-PROGRAMMED DEATH-1 (PD-1) MAB
    GCN 54945
    HICL Sequence Number 049284
    HICL Sequence Number Description TORIPALIMAB-TPZI
    Brand/Generic Brand
    Proprietary Name LOQTORZI
    Proprietary Name Suffix n/a
    Non-Proprietary Name toripalimab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 240
    Active Ingredient Units mg/6mL
    Substance Name TORIPALIMAB
    Labeler Name Coherus BioSciences, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761240
    Listing Certified Through 2024-12-31

    Package

    NDC 70114-0340-01 (70114034001)

    NDC Package Code 70114-340-01
    Billing NDC 70114034001
    Package 1 VIAL, GLASS in 1 CARTON (70114-340-01) / 6 mL in 1 VIAL, GLASS
    Marketing Start Date 2023-10-27
    NDC Exclude Flag N
    Pricing Information N/A